Harvard Bioscience, Inc. (HBIO): Price and Financial Metrics


Harvard Bioscience, Inc. (HBIO): $7.35

0.56 (+8.25%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

HBIO POWR Grades


  • Growth is the dimension where HBIO ranks best; there it ranks ahead of 97.15% of US stocks.
  • The strongest trend for HBIO is in Value, which has been heading down over the past 199 days.
  • HBIO's current lowest rank is in the Momentum metric (where it is better than 15.12% of US stocks).

HBIO Stock Summary

  • With a one year PEG ratio of 265.79, Harvard Bioscience Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 86.4% of US stocks.
  • Price to trailing twelve month operating cash flow for HBIO is currently 31.37, higher than 83.86% of US stocks with positive operating cash flow.
  • The volatility of Harvard Bioscience Inc's share price is greater than that of 74.81% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to Harvard Bioscience Inc, a group of peers worth examining would be KE, TMDX, VAPO, SILK, and AVGR.
  • HBIO's SEC filings can be seen here. And to visit Harvard Bioscience Inc's official web site, go to www.harvardbioscience.com.

HBIO Price Target

For more insight on analysts targets of HBIO, see our HBIO price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $8.75 Average Broker Recommendation 1.38 (Strong Buy)

HBIO Stock Price Chart Interactive Chart >

Price chart for HBIO

HBIO Price/Volume Stats

Current price $7.35 52-week high $7.45
Prev. close $6.79 52-week low $2.48
Day low $6.63 Volume 686,500
Day high $7.45 Avg. volume 221,276
50-day MA $6.02 Dividend yield N/A
200-day MA $4.35 Market Cap 293.46M

Harvard Bioscience, Inc. (HBIO) Company Bio


Harvard Bioscience, Inc. develops, manufactures, and markets scientific instruments, systems, and lab consumables used in life science research. The company was founded in 1901 and is based in Holliston, Massachusetts.


HBIO Latest News Stream


Event/Time News Detail
Loading, please wait...

HBIO Latest Social Stream


Loading social stream, please wait...

View Full HBIO Social Stream

Latest HBIO News From Around the Web

Below are the latest news stories about Harvard Bioscience Inc that investors may wish to consider to help them evaluate HBIO as an investment opportunity.

Are Investors Undervaluing Harvard Bioscience, Inc. (NASDAQ:HBIO) By 28%?

How far off is Harvard Bioscience, Inc. ( NASDAQ:HBIO ) from its intrinsic value? Using the most recent financial data...

Yahoo | April 21, 2021

Harvard Bioscience Schedules First Quarter 2021 Earnings Conference Call for May 6, 2021 at 8:00 AM ET

HOLLISTON, Mass., April 19, 2021 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for first quarter ended March 31, 2021 before the market opens on May 6, 2021, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time. You can access the live conference call by dialing the following phone numbers: toll-free 1 (877) 303-7611 or international 1 (970) 315-0445 and referencing the conference ID # 5876756. The conference call will be simultaneously webcast and can be accessed through the Harvard Bioscience website. To listen to the webcast, go to http://investor.harvardbioscience.com/ – Events & Presentations. Financial information presented on the call, including the earnings release and a related slide presentation, wil...

Yahoo | April 19, 2021

The Daily Biotech Pulse: Sarepta Gene Therapy Data, Idera Plunges On Failed Skin Cancer Study, 3 IPOs

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 18) AngioDynamics, Inc. (NASDAQ: ANGO ) Anixa Biosciences, Inc. (NASDAQ: ANIX ) ENDRA Life Sciences Inc. (NASDAQ: NDRA ) (announced a collaboration with Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA ) for NASH studies) Harvard Bioscience, Inc. (NASDAQ: HBIO ) Neos Therapeutics, Inc. (NASDAQ: NEOS ) (reacted to the shareholder meeting held to vote on the proposal to merge with Aytu BioScience, Inc. (NASDAQ: AYTU )) NuVasive, Inc. (NASDAQ: NUVA ) SI-BONE, Inc. (NASDAQ: SIBN ) Sierra Oncology, Inc. (NASDAQ: SRRA ) Silverback Therapeutics, Inc. (NASDAQ: SBTX ) Terns Pharmaceuticals, Inc. (NASDAQ: TERN ) Varian Medical Systems, Inc. (NASDAQ: VAR ) Veric...

Benzinga | March 19, 2021

The Daily Biotech Pulse: Translate Bio's Cystic Fibrosis Study Disappoints, Adverum Nominates Directors, Gain Therapeutics To Debut On Nasdaq

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 17) AngioDynamics, Inc. (NASDAQ: ANGO ) Anixa Biosciences, Inc. (NASDAQ: ANIX ) BioAtla, Inc. (NASDAQ: BCAB ) Harvard Bioscience, Inc. (NASDAQ: HBIO ) IDEAYA Biosciences, Inc. (NASDAQ: IDYA ) Immatics N.V. (NASDAQ: IMTX ) ( announced positive Phase 1 readout for a trio of candidates in solid tumors) NGM Biopharmaceuticals, Inc. (NASDAQ: NGM ) NuVasive, Inc. (NASDAQ: NUVA ) Omnicell, Inc. (NASDAQ: OMCL ) Oncternal Therapeutics, Inc. (NASDAQ: ONCT ) Organogenesis Holdings Inc. (NASDAQ: ORGO ) PLx Pharma Inc. (NASDAQ: PLXP ) Sierra Oncology, Inc. (NASDAQ: SRRA ) Silverback Therapeutics, Inc. (NASDAQ: SBTX ) STRATA Skin Sciences, Inc. (NASDAQ: SSKN ...

Benzinga | March 18, 2021

The Daily Biotech Pulse: Merck's Keytruda Gets Label Expansion In Europe, Pfizer To Sell Chinese Biologics Unit, Celcuity Spikes

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 16) Affimed N.V. (NASDAQ: AFMD ) BioAtla, Inc. (NASDAQ: BCAB ) Champions Oncology, Inc. (NASDAQ: CSBR ) Harvard Bioscience, Inc. (NASDAQ: HBIO ) Myriad Genetics, Inc. (NASDAQ: MYGN ) Omnicell, Inc. (NASDAQ: OMCL ) Savara Inc. (NASDAQ: SVRA ) (reacted to a positive analyst action and insider buying) Sierra Oncology, Inc. (NASDAQ: SRRA ) Sol-Gel Technologies Ltd. (NASDAQ: SLGL ) Vincerx Pharma, Inc. (NASDAQ: VINC ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows March 16) Galecto, Inc. (NASDAQ: GLTO ) Immunocore Holdings plc (NASDAQ: IMCR ) Stocks In Focus Pfizer to Sell Chinese Biologics Unit to WuXi Pfizer Inc.'s (NYSE: PFE ) China unit a...

Benzinga | March 17, 2021

Read More 'HBIO' Stories Here

HBIO Price Returns

1-mo 17.04%
3-mo 50.61%
6-mo 100.27%
1-year 190.51%
3-year 51.55%
5-year 160.64%
YTD 71.33%
2020 40.66%
2019 -4.09%
2018 -3.64%
2017 8.20%
2016 -12.10%

Continue Researching HBIO

Want to see what other sources are saying about Harvard Bioscience Inc's financials and stock price? Try the links below:

Harvard Bioscience Inc (HBIO) Stock Price | Nasdaq
Harvard Bioscience Inc (HBIO) Stock Quote, History and News - Yahoo Finance
Harvard Bioscience Inc (HBIO) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7858 seconds.